A. Rangachari

Membrane-altering effects of velnacrine and N-methylacridinium: relevance to tacrine and Alzheimer's disease.

D. Butterfield, A. Rangachari, 1992, Biochemical and biophysical research communications.

Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein 3 during the First Year in Term and Preterm Infants

W. Koo, S. Carlson, A. Rangachari, 1995, Pediatric Research.

Effects of domain-specific erythrocyte membrane modulators on acetylcholinesterase and NADH:cytochrome b5 reductase activities.

D. Butterfield, A. Rangachari, D. A. Palmieri, 1990, Archives of biochemistry and biophysics.

Electron paramagnetic resonance studies of the effects of tri-n-butyltin on the physical state of proteins and lipids in erythrocyte membranes.

D. Butterfield, A. Rangachari, A. M. Schneider, 1991, Chemical research in toxicology.

Automated Multiplex Assay System for Simultaneous Detection of Hepatitis B Virus DNA, Hepatitis C Virus RNA, and Human Immunodeficiency Virus Type 1 RNA

T. Hirose, C. Impraim, S. Tamatsukuri, 2001, Journal of Clinical Microbiology.

Acetylcarnitine increases membrane cytoskeletal protein-protein interactions.

D. Butterfield, A. Rangachari, 1993, Life sciences.

Spin labeling studies of the interactions of potentially useful therapeutic agents for the treatment of Alzheimer’s disease with cytoskeletal proteins in erythrocyte ghosts and brain synaptosomal membranes

D. Butterfield, A. Rangachari, D. Isbell, 1992 .